Ledger.Open graph →
SEC Form D · filed April 4, 2014

NEUROPHAGE PHARMACEUTICALS INC

Offering
$17.1M
Sold
$5.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Hampus Hillerstrom · Cambridge, MAExecVicki Sato · Cambridge, MADirectorJohn Dee · Cambridge, MADirectorPaul Goldenheim · Cambridge, MADirectorJonathan Solomon · Cambridge, MAExec · DirectorKenneth Buckfire · Cambridge, MADirectorPeter Smedvig · Cambridge, MADirectorJohn Bowers · Goleta, CADirectorVictoria Katsov · Goleta, CAExec · DirectorEdgar Masri · Goleta, CADirectorCarmela M. Guerrero · Cleveland, OHExecJosh M. Brown · Cleveland, OHDirectorJess Ravich · LOS ANGELES, CADirectorFrancois Valencony · Cambridge, MADirectorPeter Smedvig · Cambridge, MADirectorNico Dosenbach · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗